As a result formal statistical testing was not performed on the final two composite endpoints which were not powered for statistical significance given the short duration of the study  allcause mortality and frequency of allcause hospitalizations and urgent heart failure visits in patients not on tafamidis at baseline nominal pvalue 09888 and in the overall population nominal pvalue 05609